Mismatch repair deficiency predicts worse survival despite adjuvant treatment in stage I endometrial cancer: Opportunities for novel adjuvant therapy

Authors
Category Primary study
JournalGynecologic Oncology
Year 2020
This article has no abstract
Epistemonikos ID: ce6714e9f40796902c5a5576f33425e1fb4bfb9f
First added on: Feb 12, 2025